An Imaging Toolkit for Physical Characterization of Long-Acting Pharmaceutical Implants.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
09 2020
Historique:
received: 19 03 2020
revised: 26 05 2020
accepted: 27 05 2020
pubmed: 14 6 2020
medline: 22 6 2021
entrez: 14 6 2020
Statut: ppublish

Résumé

In pharmaceutical development alternative drug delivery modalities are being increasingly employed. One example is an implant, which achieves gradual drug release in patients over a period of many months or years. Due to the complexity of these long-acting formulations, advanced physical characterization methods are desirable as screening tools during protracted formulation development. Imaging methods are of particular interest due to their ability to interrogate the structure and composition of implants spatially across multiple length scales (macro, micro, nano). In this work, spatiochemical imaging is shown to interrogate many crucial drug product attributes of solid implants: overall implant structure, drug distribution, micro-domain size and orientation, agglomeration, porosity and defects, drug/excipient interface, dissolution process, and release mechanism. Imaging methods facilitate a detailed understanding of the process/structure correlation to inform on formulation selection, process parameter optimization, and batch consistency. Numerous case studies of implant applications with imaging are discussed. Methods utilized are X-ray computed tomography (XRCT), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS) imaging, and Raman microscopy. The imaging data is complemented with solid-state nuclear magnetic resonance (ssNMR). Altogether, these examples demonstrate that complementary imaging methods are highly effective for analyzing complex and novel pharmaceutical modalities such as solid implants.

Identifiants

pubmed: 32534030
pii: S0022-3549(20)30308-7
doi: 10.1016/j.xphs.2020.05.031
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2798-2811

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Daniel Skomski (D)

Merck & Co., Inc., Rahway, New Jersey 07065. Electronic address: dskomski@indiana.edu.

Zhen Liu (Z)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Yongchao Su (Y)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Christopher T John (CT)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Amy Doty (A)

Merck & Co., Inc., Boston, Massachusetts 02115.

Seth P Forster (SP)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Ryan Teller (R)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Stephanie E Barrett (SE)

Merck & Co., Inc., Rahway, New Jersey 07065.

Wei Xu (W)

Merck & Co., Inc., West Point, Pennsylvania 19486.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH